Related Experiment Video

Updated: Jun 12, 2026

Preparation of Washed Human Platelets for Quantitative Metabolic Flux Studies
07:06

Preparation of Washed Human Platelets for Quantitative Metabolic Flux Studies

Published on: January 10, 2025

Influence of glycaemic control on platelet bound CD40-CD40L system, P-selectin and soluble CD40 ligand in Type 2

H Neubauer1, P Setiadi, B Günesdogan

  • 1Medical Clinic II, St. Josef Hospital, Ruhr University Bochum, Bochum, Germany. horst.neubauer@rub.de

Diabetic Medicine : a Journal of the British Diabetic Association
|June 12, 2010
PubMed

Insights

Type 2 diabetes elevates platelet activation markers, including CD40-CD40L signaling and P-selectin expression. Improving glycemic control in diabetic patients significantly reduces these markers, indicating a potential therapeutic target.

Area of Science:

  • Cardiovascular Research
  • Endocrinology
  • Immunology

Background:

  • Type 2 diabetes mellitus (T2DM) is a significant risk factor for cardiovascular disease.
  • T2DM is characterized by proinflammatory and prothrombotic processes.
  • Platelet activation plays a crucial role in the pathogenesis of T2DM complications.

Purpose of the Study:

  • To investigate elevated platelet-bound CD40-CD40L signaling, P-selectin expression, and soluble CD40L in T2DM patients.
  • To determine if improved glycemic control can normalize these markers in T2DM.

Main Methods:

  • Flow cytometry was used to measure soluble CD40L, platelet CD40L, CD40, and P-selectin (CD62P) in 71 T2DM patients and 37 controls.
  • HbA1c levels were correlated with CD40-CD40L and P-selectin expression in a longitudinal follow-up study.

Main Results:

  • T2DM patients exhibited significantly higher platelet CD40 expression, platelet-bound CD40L, surface CD62P, and plasma sCD40L compared to controls.
  • In patients with initial HbA1c > 8.5%, improved glycemic control led to significant reductions in platelet P-selectin and CD40-CD40L expression after one year.

Conclusions:

  • Type 2 diabetes is linked to increased platelet activation, evidenced by up-regulation of the CD40-CD40L system and enhanced P-selectin expression.
  • Effective glycemic control can reverse abnormal platelet activation by down-regulating these key markers.
Abstract

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a significant...